The key role of membranes in amyloid formation from a biophysical perspective

Current Protein and Peptide Science

Volumn 12, Issue 3, 2011, Pages 166-180

  Torres Bugeau, Clarisa M ^a   Borsarelli, Claudio D ^b   Minahk, Carlos J ^a   Chehín, Rosana N ^a  

^a Instituto Superior de Investigaciones Biologicas   (Argentina)

^b UNIVERSIDAD NACIONAL DE SANTIAGO DEL ESTERO   (Argentina)

Author keywords

Alpha synuclein; Amyloid beta; Amyloids; Gapdh; Membranes; Neurodegenerative diseases; Oxidative stress; Proteins

Indexed keywords

AMYLIN; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; GANGLIOSIDE GM1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; SPHINGOMYELIN; STEFIN B; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; AMYLOIDOGENESIS; ATOMIC FORCE MICROSCOPY; BINDING COMPETITION; CONCENTRATION (PARAMETERS); CYTOPLASM; CYTOTOXICITY; DEGENERATIVE DISEASE; DIELECTRIC CONSTANT; HISTOGENESIS; HUMAN; HYDROPHOBICITY; KIDNEY POLYCYSTIC DISEASE; LEWY BODY; LIPID PEROXIDATION; MEMBRANE POTENTIAL; MICROENVIRONMENT; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NEUROTOXICITY; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PH; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SULFOLOBUS SOLFATARICUS; THERMODYNAMICS;

AMYLOID; BIOPHYSICS; CELL MEMBRANE; HUMANS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PROTEOSTASIS DEFICIENCIES; THERMODYNAMICS;

EID: 79959289534     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/138920311795860197     Document Type: Review

References (165)

1. Marsh, D. in New Comprehensive Biochemistry: Protein-Lipid Interactions (Watts, A., ed) Elsevier Science Publishers B.V., Amsterdam, 1993, 25, 41-66.
2. Sasahara, K.; Hall, D.; Hamada, D. Effect of lipid type on the binding of lipid vesicles to islet amyloid polypeptide amyloid fibrils. Biochemistry, 2010, 49 (14), 3040-8.
3. Gorbenko, G.P.; Kinnunen, P.K. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem. Phys. Lipids, 2006, 141 (1-2), 72-82.
4. Modi, H.R.; Katyare, S.S.; Patel, M.A. Ageing-induced alterations in lipid/phospholipid profiles of rat brain and liver mitochondria: implications for mitochondrial energy-linked functions. J. Membr. Biol., 2008, 221 (1), 51-60.
5. Giusto, N.M.; Salvador, G.A.; Castagnet, P.I.; Pasquare, S.J.; Ilincheta de Boschero, M.G. Age-associated changes in central nervous system glycerolipid composition and metabolism. Neurochem. Res., 2002, 27 (11), 1513-23.
6. Butterfield, D.A.; Galvan, V.; Lange, M.B.; Tang, H.; Sowell, R.A.; Spilman, P.; Fombonne, J.; Gorostiza, O.; Zhang, J.; Sultana, R.; Bredesen, D.E. In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. Free Radic. Biol. Med., 2010, 48 (1), 136-44.
7. Tsang, A.H.; Chung, K.K. Oxidative and nitrosative stress in Parkinson's disease. Biochim. Biophys. Acta, 2009, 1792 (7), 643-50.
8. Benhar, M.; Forrester, M.T.; Stamler, J.S. Nitrosative stress in the ER: a new role for S-nitrosylation in neurodegenerative diseases. ACS Chem. Biol., 2006, 1 (6), 355-8.
9. Koppaka, V.; Axelsen, P.H. Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes. Biochemistry, 2000, 39 (32), 10011-6.
10. Butterfield, D.A.; Bader Lange, M.L.; Sultana, R. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease. Biochim. Biophys. Acta, 2010, 1801 (8), 924-9.
11. Liu, L.; Komatsu, H.; Murray, I.V.; Axelsen, P.H. Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product. J. Mol. Biol., 2008, 377 (4), 1236-50.
12. Folch-Pi, J. The composition of nervous membranes. Prog. Brain Res., 1968, 29, 1-17.
13. Kreps, E.M. [Evolutionary aspects of the phospholipid composition of cell membranes of the nervous system]. Ukr. Biokhim. Zh., 1965, 37 (5), 734-41.
14. Dunker, A.K.; Brown, C.J.; Lawson, J.D.; Iakoucheva, L.M.; Obradovic, Z. Intrinsic disorder and protein function. Biochemistry, 2002, 41 (21), 6573-82.
15. Lu, D., Lui, Z. Studies of protein folding pathways. Annu. Rep. Prog. Chem. Sect. C, 2010, 106, 259-273.
16. Clark, P.L. Protein folding in the cell: reshaping the folding funnel. Trends Biochem. Sci., 2004, 29 (10), 527-34.
17. Cooper, A. Thermodynamic analysis of biomolecular interactions. Curr. Opin. Chem. Biol., 1999, 3 (5), 557-63.
18. Pace, C.N. Conformational stability of globular proteins. Trends Biochem. Sci., 1990, 15 (1), 14-7.
19. Anfinsen, C.B.; Haber, E. Studies on the reduction and reformation of protein disulfide bonds. J. Biol. Chem., 1961, 236, 1361-3.
20. Stefani, M.; Dobson, C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med., 2003, 81 (11), 678-99.
21. Ladokhin, A.S.; White, S.H. Interfacial folding and membrane insertion of a designed helical peptide. Biochemistry, 2004, 43 (19), 5782-91.
22. Clayton, A.H.; Vultureanu, A.G.; Sawyer, W.H. Unfolding of class A amphipathic peptides on a lipid surface. Biochemistry, 2003, 42 (6), 1747-53.
23. Cserhati, T.; Szogyi, M. Interaction of phospholipids with proteins and peptides. New advances IV. Int. J. Biochem., 1994, 26 (1), 1-18.
24. Zhao, H.; Tuominen, E.K.; Kinnunen, P.K. Formation of amyloid fibers triggered by phosphatidylserine-containing membranes. Biochemistry, 2004, 43 (32), 10302-7.
25. Cortez, L.M.; Avila, C.L.; Bugeau, C.M.; Farias, R.N.; Morero, R.D.; Chehin, R.N. Glyceraldehyde-3-phosphate dehydrogenase tetramer dissociation and amyloid fibril formation induced by negatively charged membranes. FEBS Lett., 2010, 584 (3), 625-30.
26. Engelman, D.M. Membranes are more mosaic than fluid. Nature, 2005, 438 (7068), 578-80.
27. Popot, J.L.; Engelman, D.M. Membrane protein folding and oligomerization: the two-stage model. Biochemistry, 1990, 29 (17), 4031-7.
28. Bowie, J.U. Solving the membrane protein folding problem. Nature, 2005, 438 (7068), 581-9.
29. Vacha, R.; Jurkiewicz, P.; Petrov, M.; Berkowitz, M.L.; Bockmann, R.A.; Barucha-Kraszewska, J.; Hof, M.; Jungwirth, P. Mechanism of interaction of monovalent ions with phosphatidylcholine lipid membranes. J. Phys. Chem. B, 2010, 114 (29), 9504-9.
30. Stankowski, S. Surface charging by large multivalent molecules. Extending the standard Gouy-Chapman treatment. Biophys. J., 1991, 60 (2), 341-51.
31. Yi, M.; Nymeyer, H.; Zhou, H.X. Test of the Gouy-Chapman theory for a charged lipid membrane against explicit-solvent molecular dynamics simulations. Phys. Rev. Lett., 2008, 101 (3), 038103.
32. Beschiaschvili, G.; Seelig, J. Melittin binding to mixed phosphatidylglycerol/phosphatidylcholine membranes. Biochemistry, 1990, 29 (1), 52-8.
33. Lee, C.C.; Sun, Y.; Huang, H.W. Membrane-mediated peptide conformation change from alpha-monomers to beta-aggregates. Biophys. J., 2010, 98 (10), 2236-45.
34. Terzi, E.; Holzemann, G.; Seelig, J. Self-association of betaamyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol., 1995, 252 (5), 633-42.
35. Terzi, E.; Holzemann, G.; Seelig, J. Interaction of Alzheimer betaamyloid peptide(1-40) with lipid membranes. Biochemistry, 1997, 36 (48), 14845-52.
36. Pieri, L.; Bucciantini, M.; Guasti, P.; Savistchenko, J.; Melki, R.; Stefani, M. Synthetic lipid vesicles recruit native-like aggregates and affect the aggregation process of the prion Ure2p: insights on vesicle permeabilization and charge selectivity. Biophys. J., 2009, 96 (8), 3319-30.
37. Bemporad, F.; Chiti, F. Native-like aggregation of the acylphosphatase from Sulfolobus solfataricus and its biological implications. FEBS Lett., 2009, 583 (16), 2630-8.
38. Berkowitz, M.L.; Bostick, D.L.; Pandit, S. Aqueous solutions next to phospholipid membrane surfaces: insights from simulations. Chem. Rev., 2006, 106 (4), 1527-39.
39. Eisenberg, M.; Gresalfi, T.; Riccio, T.; McLaughlin, S. Adsorption of monovalent cations to bilayer membranes containing negative phospholipids. Biochemistry, 1979, 18 (23), 5213-23.
40. Kelly, J.W. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol., 1996, 6 (1), 11-7.
41. Rochet, J.C.; Lansbury, P.T., Jr. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol., 2000, 10 (1), 60-8.
42. Zerovnik, E. Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. Eur. J. Biochem., 2002, 269 (14), 3362-71.
43. Zerovnik, E. Protein conformational pathology in Alzheimer's and other neurodegenerative diseases; new targets for therapy. Curr. Alzheimer Res., 2010, 7 (1), 74-83.
44. Wimley, W.C.; Creamer, T.P.; White, S.H. Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. Biochemistry, 1996, 35 (16), 5109-24.
45. Wang, Q.; Zhao, C.; Zhao, J.; Wang, J.; Yang, J.C.; Yu, X.; Zheng, J. Comparative molecular dynamics study of Abeta adsorption on the self-assembled monolayers. Langmuir, 2010, 26 (5), 3308-16.
46. Liu, S.M.; Haynes, C.A. Energy landscapes for adsorption of a protein-like HP chain as a function of native-state stability. J. Colloid Interface Sci., 2005, 284 (1), 7-13.
47. Kinnunen, P.K. Lipid bilayers as osmotic response elements. Cell Physiol. Biochem., 2000, 10 (5-6), 243-50.
48. Ellis, R.J. Macromolecular crowding: obvious but underappreciated. Trends Biochem. Sci., 2001, 26 (10), 597-604.
49. Kilburn, D.; Roh, J.H.; Guo, L.; Briber, R.M.; Woodson, S.A. Molecular crowding stabilizes folded RNA structure by the excluded volume effect. J. Am. Chem. Soc., 2010, 132 (25), 8690-6.
50. Zhou, H.X.; Rivas, G.; Minton, A.P. Macromolecular crowding and confinement: biochemical, biophysical, and potential physiological consequences. Annu. Rev. Biophys., 2008, 37, 375-97.
51. Xu, S. Cross-beta-sheet structure in amyloid fiber formation. J. Phys. Chem. B, 2009, 113 (37), 12447-55.
52. Milner-White, J.E.; Watson, J.D.; Qi, G.; Hayward, S. Amyloid formation may involve alpha- to beta sheet interconversion via peptide plane flipping. Structure, 2006, 14 (9), 1369-76.
53. Kirkitadze, M.D.; Condron, M.M.; Teplow, D.B. Identification and characterization of key kinetic intermediates in amyloid betaprotein fibrillogenesis. J. Mol. Biol., 2001, 312 (5), 1103-19.
54. Klimov, D.K.; Thirumalai, D. Dissecting the assembly of Abeta16-22 amyloid peptides into antiparallel beta sheets. Structure, 2003, 11 (3), 295-307.
55. Ryan, T.A.; Myers, J.; Holowka, D.; Baird, B.; Webb, W.W. Molecular crowding on the cell surface. Science, 1988, 239 (4835), 61-4.
56. Heimburg, T.; Marsh, D. Protein surface-distribution and proteinprotein interactions in the binding of peripheral proteins to charged lipid membranes. Biophys. J., 1995, 68 (2), 536-46.
57. Elcock, A.H. Models of macromolecular crowding effects and the need for quantitative comparisons with experiment. Curr. Opin. Struct. Biol., 2010, 20 (2), 196-206.
58. Aisenbrey, C.; Bechinger, B.; Grobner, G. Macromolecular crowding at membrane interfaces: adsorption and alignment of membrane peptides. J. Mol. Biol., 2008, 375 (2), 376-85.
59. Fan, J.; Sammalkorpi, M.; Haataja, M. Formation and regulation of lipid microdomains in cell membranes: theory, modeling, and speculation. FEBS Lett., 2010, 584 (9), 1678-84.
60. Pike, L.J. Lipid rafts: bringing order to chaos. J. Lipid Res., 2003, 44 (4), 655-67.
61. L.J. The challenge of lipid rafts. J. Lipid Res., 2009, 50 Suppl, S323-8.
62. Yanagisawa, K.; Matsuzaki, K. Cholesterol-dependent aggregation of amyloid beta-protein. Ann. NY Acad. Sci., 2002, 977, 384-6.
63. Lingwood, D.; Simons, K. Lipid rafts as a membrane-organizing principle. Science, 2010, 327 (5961), 46-50.
64. Owen, D.M.; Neil, M.A.; French, P.M.; Magee, A.I. Optical techniques for imaging membrane lipid microdomains in living cells. Semin. Cell Dev. Biol., 2007, 18 (5), 591-8.
65. Owen, D.M.; Gaus, K.; Magee, A.I.; Cebecauer, M. Dynamic organization of lymphocyte plasma membrane: lessons from advanced imaging methods. Immunology, 2010, 131 (1), 1-8.
66. Oncul, S.; Klymchenko, A.S.; Kucherak, O.A.; Demchenko, A.P.; Martin, S.; Dontenwill, M.; Arntz, Y.; Didier, P.; Duportail, G.; Mely, Y. Liquid ordered phase in cell membranes evidenced by a hydration-sensitive probe: effects of cholesterol depletion and apoptosis. Biochim. Biophys. Acta, 2010, 1798 (7), 1436-43.
67. de Almeida, R.F.; Loura, L.M.; Prieto, M. Membrane lipid domains and rafts: current applications of fluorescence lifetime spectroscopy and imaging. Chem. Phys. Lipids, 2009, 157 (2), 61-77.
68. Mamdouh, Z.; Giocondi, M.C.; Le Grimellec, C. In situ determination of intracellular membrane physical state heterogeneity in renal epithelial cells using fluorescence ratio microscopy. Eur. Biophys. J., 1998, 27 (4), 341-51.
69. Wang, S.S.; Rymer, D.L.; Good, T.A. Reduction in cholesterol and sialic acid content protects cells from the toxic effects of betaamyloid peptides. J. Biol. Chem., 2001, 276 (45), 42027-34.
70. Wang, S.S.; Good, T.A.; Rymer, D.L. The influence of phospholipid membranes on bovine calcitonin secondary structure and amyloid formation. Protein Sci., 2005, 14 (6), 1419-28.
71. Nicholson, A.M.; Ferreira, A. Increased membrane cholesterol might render mature hippocampal neurons more susceptible to beta-amyloid-induced calpain activation and tau toxicity. J. Neurosci., 2009, 29 (14), 4640-51.
72. Gellermann, G.P.; Appel, T.R.; Tannert, A.; Radestock, A.; Hortschansky, P.; Schroeckh, V.; Leisner, C.; Lutkepohl, T.; Shtrasburg, S.; Rocken, C.; Pras, M.; Linke, R.P.; Diekmann, S.; Fandrich, M. Raft lipids as common components of human extracellular amyloid fibrils. Proc. Natl. Acad. Sci. USA, 2005, 102 (18), 6297-302.
73. Taylor, D.R.; Whitehouse, I.J.; Hooper, N.M. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation. PLoS Pathog., 2009, 5 (11), e1000666.
74. Kim, S.I.; Yi, J.S.; Ko, Y.G. Amyloid beta oligomerization is induced by brain lipid rafts. J. Cell Biochem., 2006, 99 (3), 878-89.
75. Beel, A.J.; Sakakura, M.; Barrett, P.J.; Sanders, C.R. Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships? Biochim. Biophys. Acta, 2010, 1801 (8), 975-82.
76. Zampagni, M.; Evangelisti, E.; Cascella, R.; Liguri, G.; Becatti, M.; Pensalfini, A.; Uberti, D.; Cenini, G.; Memo, M.; Bagnoli, S.; Nacmias, B.; Sorbi, S.; Cecchi, C. Lipid rafts are primary mediators of amyloid oxidative attack on plasma membrane. J. Mol. Med., 2010, 88 (6), 597-608.
77. Riekkinen, P.; Rinne, U.K.; Pelliniemi, T.T.; Sonninen, V. Interaction between dopamine and phospholipids. Studies of the substantia nigra in Parkinson disease patients. Arch. Neurol., 1975, 32 (1), 25-7.
78. Jha, S.; Sellin, D.; Seidel, R.; Winter, R. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes. J. Mol. Biol., 2009, 389 (5), 907-20.
79. Hou, X.; Mechler, A.; Martin, L.L.; Aguilar, M.I.; Small, D.H. Cholesterol and anionic phospholipids increase the binding of amyloidogenic transthyretin to lipid membranes. Biochim. Biophys. Acta, 2008, 1778 (1), 198-205.
80. Drescher, M.; van Rooijen, B.D.; Veldhuis, G.; Subramaniam, V.; Huber, M. A stable lipid-induced aggregate of alpha-synuclein. J. Am. Chem. Soc., 2010, 132 (12), 4080-2.
81. Zhu, M.; Li, J.; Fink, A.L. The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation. J. Biol. Chem., 2003, 278 (41), 40186-97.
82. Auluck, P.K.; Caraveo, G.; Lindquist, S. alpha-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease. Annu. Rev. Cell Dev. Biol., 2010.
83. Devanathan, S.; Salamon, Z.; Lindblom, G.; Grobner, G.; Tollin, G. Effects of sphingomyelin, cholesterol and zinc ions on the binding, insertion and aggregation of the amyloid Abeta(1-40) peptide in solid-supported lipid bilayers. FEBS J., 2006, 273 (7), 1389-402.
84. Kazlauskaite, J.; Sanghera, N.; Sylvester, I.; Venien-Bryan, C.; Pinheiro, T.J. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry, 2003, 42 (11), 3295-304.
85. Davis, C.H.; Berkowitz, M.L. Interaction between amyloid-beta (1-42) peptide and phospholipid bilayers: a molecular dynamics study. Biophys. J., 2009, 96 (3), 785-97.
86. Wang, S.S.; Good, T.A.; Rymer, D.L. The influence of phospholipid membranes on bovine calcitonin peptide's secondary structure and induced neurotoxic effects. Int. J. Biochem. Cell Biol., 2005, 37 (8), 1656-69.
87. Brown, D.A.; London, E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol., 1998, 14, 111-36.
88. Yuyama, K.; Yanagisawa, K. Sphingomyelin accumulation provides a favorable milieu for GM1 ganglioside-induced assembly of amyloid beta-protein. Neurosci. Lett., 2010, 481 (3), 168-72.
89. Cho, W.J.; Trikha, S.; Jeremic, A.M. Cholesterol regulates assembly of human islet amyloid polypeptide on model membranes. J. Mol. Biol., 2009, 393 (3), 765-75.
90. Meng, X.; Fink, A.L.; Uversky, V.N. The effect of membranes on the in vitro fibrillation of an amyloidogenic light-chain variabledomain SMA. J. Mol. Biol., 2008, 381 (4), 989-99.
91. Ji, S.R.; Wu, Y.; Sui, S.F. Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation. J. Biol. Chem., 2002, 277 (8), 6273-9.
92. Iwatsubo, T.; Odaka, A.; Suzuki, N.; Mizusawa, H.; Nukina, N.; Ihara, Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron, 1994, 13 (1), 45-53.
93. Hayashi, H.; Igbavboa, U.; Hamanaka, H.; Kobayashi, M.; Fujita, S.C.; Wood, W.G.; Yanagisawa, K. Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice. Neuroreport, 2002, 13 (4), 383-6.
94. Rymer, D.L.; Good, T.A. The role of prion peptide structure and aggregation in toxicity and membrane binding. J. Neurochem., 2000, 75 (6), 2536-45.
95. Nakazawa, Y.; Suzuki, Y.; Williamson, M.P.; Saito, H.; Asakura, T. The interaction of amyloid Abeta(1-40) with lipid bilayers and ganglioside as studied by 31P solid-state NMR. Chem. Phys. Lipids, 2009, 158 (1), 54-60.
96. Mandal, P.K.; Pettegrew, J.W. Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Abeta(1-40) peptide in a membrane mimic environment. Neurochem. Res., 2004, 29 (2), 447-53.
97. Borchelt, D.R.; Thinakaran, G.; Eckman, C.B.; Lee, M.K.; Davenport, F.; Ratovitsky, T.; Prada, C.M.; Kim, G.; Seekins, S.; Yager, D.; Slunt, H.H.; Wang, R.; Seeger, M.; Levey, A.I.; Gandy, S.E.; Copeland, N.G.; Jenkins, N.A.; Price, D.L.; Younkin, S.G.; Sisodia, S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron, 1996, 17 (5), 1005-13.
98. Okada, T.; Wakabayashi, M.; Ikeda, K.; Matsuzaki, K. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J. Mol. Biol., 2007, 371 (2), 481-9.
99. Okada, T.; Ikeda, K.; Wakabayashi, M.; Ogawa, M.; Matsuzaki, K. Formation of toxic Abeta(1-40) fibrils on GM1 gangliosidecontaining membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils. J. Mol. Biol., 2008, 382 (4), 1066-74.
100. Kakio, A.; Yano, Y.; Takai, D.; Kuroda, Y.; Matsumoto, O.; Kozutsumi, Y.; Matsuzaki, K. Interaction between amyloid betaprotein aggregates and membranes. J. Pept. Sci., 2004, 10 (10), 612-21.
101. Cuatrecasas, P. Gangliosides and membrane receptors for cholera toxin. Biochemistry, 1973, 12 (18), 3558-66.
102. Wakabayashi, M.; Okada, T.; Kozutsumi, Y.; Matsuzaki, K. GM1 ganglioside-mediated accumulation of amyloid beta-protein on cell membranes. Biochem. Biophys. Res. Commun., 2005, 328 (4), 1019-23.
103. Saavedra, L.; Mohamed, A.; Ma, V.; Kar, S.; de Chaves, E.P. Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E. J. Biol. Chem., 2007, 282 (49), 35722-32.
104. Kurganov, B.; Doh, M.; Arispe, N. Aggregation of liposomes induced by the toxic peptides Alzheimer's Abetas, human amylin and prion (106-126): facilitation by membrane-bound GM1 ganglioside. Peptides, 2004, 25 (2), 217-32.
105. Martinez, Z.; Zhu, M.; Han, S.; Fink, A.L. GM1 specifically interacts with alpha-synuclein and inhibits fibrillation. Biochemistry, 2007, 46 (7), 1868-77.
106. Beyer, K. Mechanistic aspects of Parkinson's disease: alphasynuclein and the biomembrane. Cell Biochem. Biophys., 2007, 47 (2), 285-99.
107. Muller, W.E.; Koch, S.; Eckert, A.; Hartmann, H.; Scheuer, K. beta-Amyloid peptide decreases membrane fluidity. Brain Res., 1995, 674 (1), 133-6.
108. Kremer, J.J.; Pallitto, M.M.; Sklansky, D.J.; Murphy, R.M. Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry, 2000, 39 (33), 10309-18.
109. Muller, W.E.; Eckert, G.P.; Scheuer, K.; Cairns, N.J.; Maras, A.; Gattaz, W.F. Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43. Amyloid, 1998, 5 (1), 10-5.
110. Lin, H.; Zhu, Y.J.; Lal, R. Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles. Biochemistry, 1999, 38 (34), 11189-96.
111. Ladokhin, A.S.; White, S.H. Folding of amphipathic alpha-helices on membranes: energetics of helix formation by melittin. J. Mol. Biol., 1999, 285 (4), 1363-9.
112. Vogel, H. Incorporation of melittin into phosphatidylcholine bilayers. Study of binding and conformational changes. FEBS Lett., 1981, 134 (1), 37-42.
113. Kim, Y.S.; Laurine, E.; Woods, W.; Lee, S.J. A novel mechanism of interaction between alpha-synuclein and biological membranes. J. Mol. Biol., 2006, 360 (2), 386-97.
114. Domanov, Y.A.; Kinnunen, P.K. Islet amyloid polypeptide forms rigid lipid-protein amyloid fibrils on supported phospholipid bilayers. J. Mol. Biol., 2008, 376 (1), 42-54.
115. Ceru, S.; Layfield, R.; Zavasnik-Bergant, T.; Repnik, U.; Kopitar- Jerala, N.; Turk, V.; Zerovnik, E. Intracellular aggregation of human stefin B: confocal and electron microscopy study. Biol. Cell, 2010, 102 (6), 319-34.
116. Anderluh, G.; Gutierrez-Aguirre, I.; Rabzelj, S.; Ceru, S.; Kopitar- Jerala, N.; Macek, P.; Turk, V.; Zerovnik, E. Interaction of human stefin B in the prefibrillar oligomeric form with membranes. Correlation with cellular toxicity. FEBS J., 2005, 272 (12), 3042-51.
117. Sonkina, S.; Tukhfatullina, II; Benseny-Cases, N.; Ionov, M.; Bryszewska, M.; Salakhutdinov, B.A.; Cladera, J. Interaction of the prion protein fragment PrP 185-206 with biological membranes: effect on membrane permeability. J. Pept. Sci., 16 (7), 342-8.
118. Chich, J.F.; Chapuis, C.; Henry, C.; Vidic, J.; Rezaei, H.; Noinville, S. Vesicle permeabilization by purified soluble oligomers of prion protein: a comparative study of the interaction of oligomers and monomers with lipid membranes. J. Mol. Biol., 397 (4), 1017-30.
119. Sirover, M.A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim. Biophys. Acta, 1999, 1432 (2), 159-84.
120. Tatton, W.G.; Chalmers-Redman, R.M.; Elstner, M.; Leesch, W.; Jagodzinski, F.B.; Stupak, D.P.; Sugrue, M.M.; Tatton, N.A. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J. Neural. Transm. Suppl., 2000, (60), 77-100.
121. Sunaga, K.; Takahashi, H.; Chuang, D.M.; Ishitani, R. Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain. Neurosci. Lett., 1995, 200 (2), 133-6.
122. Avila, C.L.; de Arcuri, B.F.; Gonzalez-Nilo, F.; De Las Rivas, J.; Chehin, R.; Morero, R. Role of electrostatics on membrane binding, aggregation and destabilization induced by NAD(P)H dehydrogenases. Implication in membrane fusion. Biophys. Chem., 2008, 137 (2-3), 126-32.
123. Stadtman, E.R. Role of oxidant species in aging. Curr. Med. Chem., 2004, 11 (9), 1105-12.
124. Carney, J.M.; Smith, C.D.; Carney, A.M.; Butterfield, D.A. Agingand oxygen-induced modifications in brain biochemistry and behavior. Ann. N Y Acad. Sci., 1994, 738, 44-53.
125. Butterfield, D.A.; Castegna, A.; Lauderback, C.M.; Drake, J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging, 2002, 23 (5), 655-64.
126. Butterfield, D.A.; Lauderback, C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic. Biol. Med., 2002, 32 (11), 1050-60.
127. Butterfield, D.A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic. Res., 2002, 36 (12), 1307-13.
128. Yatin, S.M.; Varadarajan, S.; Link, C.D.; Butterfield, D.A. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42). Neurobiol. Aging, 1999, 20 (3), 325-30; discussion 339-42.
129. Markesbery, W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med., 1997, 23 (1), 134-47.
130. Mark, R.J.; Lovell, M.A.; Markesbery, W.R.; Uchida, K.; Mattson, M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J. Neurochem., 1997, 68 (1), 255-64.
131. Mark, R.J.; Fuson, K.S.; May, P.C. Characterization of 8- epiprostaglandin F2alpha as a marker of amyloid beta-peptideinduced oxidative damage. J. Neurochem., 1999, 72 (3), 1146-53.
132. Murray, I.V.; Sindoni, M.E.; Axelsen, P.H. Promotion of oxidative lipid membrane damage by amyloid beta proteins. Biochemistry, 2005, 44 (37), 12606-13.
133. Komatsu, H.; Liu, L.; Murray, I.V.; Axelsen, P.H. A mechanistic link between oxidative stress and membrane mediated amyloidogenesis revealed by infrared spectroscopy. Biochim. Biophys. Acta, 2007, 1768 (8), 1913-22.
134. Tamagno, E.; Guglielmotto, M.; Aragno, M.; Borghi, R.; Autelli, R.; Giliberto, L.; Muraca, G.; Danni, O.; Zhu, X.; Smith, M.A.; Perry, G.; Jo, D.G.; Mattson, M.P.; Tabaton, M. Oxidative stress activates a positive feedback between the gamma- and betasecretase cleavages of the beta-amyloid precursor protein. J. Neurochem., 2008, 104 (3), 683-95.
135. Murray, I.V.; Liu, L.; Komatsu, H.; Uryu, K.; Xiao, G.; Lawson, J.A.; Axelsen, P.H. Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins. J. Biol. Chem., 2007, 282 (13), 9335-45.
136. Castegna, A.; Thongboonkerd, V.; Klein, J.B.; Lynn, B.; Markesbery, W.R.; Butterfield, D.A. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem., 2003, 85 (6), 1394-401.
137. Castegna, A.; Lauderback, C.M.; Mohmmad-Abdul, H.; Butterfield, D.A. Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4- hydroxynonenal and acrolein: implications for Alzheimer's disease. Brain Res., 2004, 1004 (1-2), 193-7.
138. Mohmmad Abdul, H.; Butterfield, D.A. Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease. Biochim. Biophys. Acta, 2005, 1741 (1-2), 140-8.
139. Koshimura, K.; Nakamura, S.; Miwa, S.; Fujiwara, M.; Kameyama, M. Regional difference in the kinetics of choline acetyltransferase in brains of neurologically normal elderly people and those with Alzheimer-type dementia. J. Neurol. Sci., 1988, 84 (2-3), 141-6.
140. Koppal, T.; Subramaniam, R.; Drake, J.; Prasad, M.R.; Dhillon, H.; Butterfield, D.A. Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomalmembrane lipid structure and composition. Brain Res., 1998, 786 (1-2), 270-3.
141. Yatin, S.M.; Varadarajan, S.; Butterfield, D.A. Vitamin E Prevents Alzheimer's Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production. J. Alzheimers Dis., 2000, 2 (2), 123-131.
142. Kanski, J.; Aksenova, M.; Stoyanova, A.; Butterfield, D.A. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J. Nutr. Biochem., 2002, 13 (5), 273-281.
143. Dhitavat, S.; Ortiz, D.; Rogers, E.; Rivera, E.; Shea, T.B. Folate, vitamin E, and acetyl-L-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid-beta. Brain Res., 2005, 1061 (2), 114-7.
144. Martin, F.L.; Williamson, S.J.; Paleologou, K.E.; Allsop, D.; El- Agnaf, O.M. Alpha-synuclein and the pathogenesis of Parkinson's disease. Protein Pept. Lett., 2004, 11 (3), 229-37.
145. Polymeropoulos, M.H.; Lavedan, C.; Leroy, E.; Ide, S.E.; Dehejia, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; Boyer, R.; Stenroos, E.S.; Chandrasekharappa, S.; Athanassiadou, A.; Papapetropoulos, T.; Johnson, W.G.; Lazzarini, A.M.; Duvoisin, R.C.; Di Iorio, G.; Golbe, L.I.; Nussbaum, R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 1997, 276 (5321), 2045-7.
146. Zhang, Y.; Dawson, V.L.; Dawson, T.M. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis., 2000, 7 (4), 240-50.
147. Fink, A.L. The aggregation and fibrillation of alpha-synuclein. Acc. Chem. Res., 2006, 39 (9), 628-34.
148. Uversky, V.N. Alpha-synuclein misfolding and neurodegenerative diseases. Curr. Protein Pept. Sci., 2008, 9 (5), 507-40.
149. Shvadchak, V.V.F.-L., Yushchenko, L.J.; Jovin, T.M. Interactions of a-synuclein with lipids and artificial membranes monitored by ESIPT probes. R. Jelinek (ed.): Germany, In press.
150. Cole, N.B.; Murphy, D.D.; Grider, T.; Rueter, S.; Brasaemle, D.; Nussbaum, R.L. Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein. J. Biol. Chem., 2002, 277 (8), 6344-52.
151. Stockl, M.; Fischer, P.; Wanker, E.; Herrmann, A. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquiddisordered domains. J. Mol. Biol., 2008, 375 (5), 1394-404.
152. Andrekopoulos, C.; Zhang, H.; Joseph, J.; Kalivendi, S.; Kalyanaraman, B. Bicarbonate enhances alpha-synuclein oligomerization and nitration: intermediacy of carbonate radical anion and nitrogen dioxide radical. Biochem. J., 2004, 378 (Pt 2), 435-47.
153. Perrin, R.J.; Woods, W.S.; Clayton, D.F.; George, J.M. Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J. Biol. Chem., 2001, 276 (45), 41958-62.
154. Giasson, B.I.; Duda, J.E.; Murray, I.V.; Chen, Q.; Souza, J.M.; Hurtig, H.I.; Ischiropoulos, H.; Trojanowski, J.Q.; Lee, V.M. Oxidative damage linked to neurodegeneration by selective alphasynuclein nitration in synucleinopathy lesions. Science, 2000, 290 (5493), 985-9.
155. Takahashi, T.; Yamashita, H.; Nakamura, T.; Nagano, Y.; Nakamura, S. Tyrosine 125 of alpha-synuclein plays a critical role for dimerization following nitrative stress. Brain Res., 2002, 938 (1-2), 73-80.
156. Hodara, R.; Norris, E.H.; Giasson, B.I.; Mishizen-Eberz, A.J.; Lynch, D.R.; Lee, V.M.; Ischiropoulos, H. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. J. Biol. Chem., 2004, 279 (46), 47746-53.
157. Zhu, M.; Qin, Z.J.; Hu, D.; Munishkina, L.A.; Fink, A.L. Alphasynuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles. Biochemistry, 2006, 45 (26), 8135-42.
158. Hokenson, M.J.; Uversky, V.N.; Goers, J.; Yamin, G.; Munishkina, L.A.; Fink, A.L. Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein. Biochemistry, 2004, 43 (15), 4621-33.
159. Borsarelli, C.D.O., V.; Fauerbach J.A., Jovin T.M. In Structural changes in alfa-synuclein labelled with photosensitizers., XVI Argentine Congress of Physical Chemistry and Inorganic Chemistry, May 18th-22th; 2010.
160. Butterfield, D.A.; Hardas, S.S.; Lange, M.L. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration. J. Alzheimers Dis., 2010, 20 (2), 369-93.
161. Nakajima, H.; Amano, W.; Fujita, A.; Fukuhara, A.; Azuma, Y.T.; Hata, F.; Inui, T.; Takeuchi, T. The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death. J. Biol. Chem., 2007, 282 (36), 26562-74.
162. Dioudis, C.; Dimitrios, G.; Thomas, T.H.; West, I.C. Abnormal glyceraldehyde-3-phosphate dehydrogenase binding and glycolytic flux in Autosomal Dominant Polycystic Kidney Disease after a mild oxidative stress. Hippokratia, 2008, 12 (3), 162-7.
163. Hardy, J.; Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002, 297 (5580), 353-6.
164. Lashuel, H.A.; Petre, B.M.; Wall, J.; Simon, M.; Nowak, R.J.; Walz, T.; Lansbury, P.T., Jr. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J. Mol. Biol., 2002, 322 (5), 1089-102.
165. Uversky, V.N.; Eliezer, D. Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. Curr. Protein Pept. Sci., 2009, 10 (5), 483-99.